期刊文献+

视黄醇结合蛋白4与慢性丙型肝炎合并肝脂肪变性的关系

在线阅读 下载PDF
导出
摘要 目的探讨血清视黄醇结合蛋,白4(RBP4)是否是CHC合并肝脂肪变性的重要因素。方法收集42例慢性丙型肝炎(CHC)患者的病历资料进行回顾性分析。根据病理组织学结果将42例患者分为观察组(CHC合并肝脂肪变组)和对照组(CHC不合并肝脂肪变组),比较2组肝功能、TG、TC、胰岛素抵抗指数(HOMA.IR)、BMI和RBP4。结果观察组ALT、AST、1谷氨酰转移酶、TG、TC均高于对照组,组间差异均有统计学意义(P〈0.05);观察组HOMA.IR(4±3)高于对照组(1.5±0.4),组间差异有统计学意义(P〈0.05);观察组BMI[(28.1±4.1)kg/m^2]高于对照组[(23.3±1.2)kg/m^2],差异有统计学意义(P〈0.05);观察组RBP4[(17.1±0.6)μg/m1]与对照组[(17.0±0.7)μg/ml]比较,差异无统计学意义(P〉0.05);血清RBP4与HOMA-IR间呈负相关(r=-0.6368,P〈0.05),RBP4与BMI间无相关性(r=0.159,P〉0.05)。结论RBP4在CHC合并肝脂肪变的发生和发展过程中并不是一个重要的因素,可进一步扩大样本量及跟踪CHC合并肝脂肪变病程,再对RBP4水平进行监测,同时可利用不含添加剂的玻璃真空管收集血液以及定量的蛋白质印迹方法进一步完善实验方法,深入了解RBP4和CHC合并肝脂肪变的关系。
作者 邱秀霞 左苗
出处 《中国医药》 2012年第9期1113-1114,共2页 China Medicine
  • 相关文献

参考文献14

  • 1Adinolfi LE, Gambardella M, Andreana A, et al. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology ,2001,33(6) :1358-1364.
  • 2柴英娟,王劲松,邓兰兰,张燕,刘铂颖.北京市宣武区中老年人非酒精性脂肪肝患病率及相关因素分析[J].中国基层医药,2011,18(23):3181-3182. 被引量:14
  • 3Yang Q, Graham TE, Mody N, et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature ,2005,436 (7049) :356-362.
  • 4病毒性肝炎防治方案[J].中华传染病杂志,2001,19(1):56-62. 被引量:1829
  • 5吴萍,陈红,李秋贞,闫淑花,范琦丽.慢性丙型肝炎患者血清视黄醇结合蛋白4水平及相关影响因素的研究[J].中国医师进修杂志,2010,33(18):6-9. 被引量:2
  • 6周华坚,杨小云,曾宏.聚乙二醇干扰素治疗慢性丙型肝炎疗效观察[J].中国基层医药,2009,16(2):221-222. 被引量:5
  • 7Graham TE, Yang Q, Bltiher M, et al. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med,2006,354(24) :2552-2563.
  • 8Cho YM,Youn BS, Lee H, et al. Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes. Diabetes Care ,2006,29( 11 ) :2457- 2461.
  • 9Vanitallie TB. Frailty in the elderly: contributions of sarcopenia andvisceral protein depletion. Metabolism,2003,52(10 Suppl 2) : 22 -26.
  • 10Graham TE, Wason C J, Bltlher M, et al. Shortcomings in methodology complicate measurements of serum retinol binding protein (RBP4) in insulin-resistant human subjects. Diabetologia, 2007,50 (4) :814-823.

二级参考文献54

  • 1张华捷,庄辉,刘学恩.脂肪肝的流行病学研究进展[J].中华流行病学杂志,2004,25(7):630-632. 被引量:107
  • 2丙型肝炎防治指南[J].临床肝胆病杂志,2004,20(4):197-203. 被引量:735
  • 3黄阿农,郑苏芹,童郁韫.抗丙型肝炎病毒新药——聚乙二醇干扰素[J].医药导报,2004,23(10):779-780. 被引量:3
  • 4Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..非酒精性脂肪性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):161-163. 被引量:1517
  • 5南月敏,吴文娟,王蕾.脂肪肝诊断进展[J].临床荟萃,2006,21(19):1432-1434. 被引量:15
  • 6Schiffman M, Pockros P J, Reddy R K,et al. A controlled,randomized multicenter, descending dose phase Ⅱ trial of pegvlated inteffemnct-2a(PEG) vs standard inteffemnα-2a (IFN) fortreatment of chronic hepatitisC. Gastroenterology, 1999,116 ( 2 ) : 1275- 1277.
  • 7Fried MW, Shiffman ML, Reddy K R, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med, 2002,347 ( 13 ) :975-982.
  • 8Liang TJ,Rehermann B,Seeff LB,et al. Pathogenesis,natural history,treatment,and prevention of hepatitis C. Ann Intern Med,2000,132(4):296-305.
  • 9Asselah T,Rubbia-Brandt L,Marcellin P,et al. Steatosis in chronic hepatitis C: why does it really matter? Gut,2006,55 (1):123-130.
  • 10Stefan N,Hennige AM,Staiger H,et al. High circulating retinolbinding protein 4 is associated with elevated liver fat but not with total,subcutaneous,visceral,or intramyocellular fat in hunans. Diabetes Care,2007,30(5): 1173-1178.

共引文献1855

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部